Alopecia areata (AA) is an autoimmune skin disease characterized by abnormal levels of several cytokines, such as interferon alpha (IFN-α) and tumor necrosis factor-alpha (TNF-α), which are T-helper type 1 …
Sublingual tofacitinib for alopecia areata: a roll-over pilot clinical trial and analysis of pharmacokinetics.
Tofacitinib is a JAK1/3 inhibitor used off-label to treat alopecia areata (AA). Oral tofacitinib undergoes extensive hepatic metabolism and has numerous drug interactions and a half-life of 3 hours necessitating twice …
Most Hospitals Not Publicly Posting Price Data
More than half of hospitals do not have publicly accessible data online, per CMS rule
Brand-Name Competition for Diabetes Drugs Has Variable Impact on Net Prices
And, one in five generic drugs sold in U.S. experienced price spikes initiated by manufacturers during 2014 to 2017
CDC Deputy Director Schuchat to Retire
Schuchat joined the CDC in 1988 and had key roles in many health crises